AKT1 and atherosclerosis: Withaferin A, a bioactive compound in Ashwagandha, modulated oxidative damage by regulating inflammatory mediators and apoptosis through the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway in high-cholesterol-induced atherosclerosis in experimental rats [69].